Effect of camostat mesilate on puromycin aminonucleoside nephrotic rats.
Suzuki
J
J
Suzuki
S
S
Nozawa
R
R
Kumaki
S
S
Kume
K
K
Higuchi
E
E
Kamiyama
S
S
Ohara
N
N
Yugeta
E
E
Kato
K
K
D015121:6-Ketoprostaglandin F1 alpha / Q000652:urine; D000818:Animals; D004952:Esters; D016670:Gabexate / Q000031:analogs & derivatives*; D006146:Guanidines / Q000627:therapeutic use*; D008297:Male; D009401:Nephrosis / Q000139:chemically induced / Q000188:drug therapy*; D011480:Protease Inhibitors / Q000627:therapeutic use*; D011692:Puromycin Aminonucleoside; D051381:Rats; D011919:Rats, Inbred Strains; D013929:Thromboxane B2 / Q000652:urine
D004952:Esters; D006146:Guanidines; D011480:Protease Inhibitors; C034532:camostat; D016670:Gabexate; D013929:Thromboxane B2; D011692:Puromycin Aminonucleoside; D015121:6-Ketoprostaglandin F1 alpha